从“虚实”两端论治强直性脊柱炎
Treating Ankylosing Spondylitis from Both “Deficiency and Excess” Syndromes
DOI: 10.12677/jcpm.2025.46479, PDF,   
作者: 张 睿, 何宴徽:黑龙江中医药大学研究生院,黑龙江 哈尔滨;高丽娟*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;黑龙江中医药大学附属第一医院风湿病科,黑龙江 哈尔滨
关键词: 强直性脊柱炎大偻本虚标实病因病机Ankylosing Spondylitis Large Spondylitis Root Deficiency with Branch Excess Etiology and Pathogenesis
摘要: 强直性脊柱炎是一种以慢性炎症为主要特征的难治性疾病,其病理改变主要累及骶髂关节、脊柱中轴及外周关节,并可伴随多种关节外表现。若病情进展至晚期,患者可能出现脊柱强直及结构性畸形,严重影响生活质量。目前,现代医学对其发病机制尚未完全阐明,而中医学则将其归为“痹证”范畴,并以“大偻”命名,认为其病机特点在于“本虚标实”。基于这一理论,本文围绕虚、实两大病机关键,系统探讨强直性脊柱炎的辨证论治策略,以期为临床实践提供新的诊疗思路。
Abstract: Ankylosing spondylitis is an intractable disease characterized by chronic inflammation, and its pathological changes mainly involve the sacroiliac joints, spinal mid-axis and peripheral joints, and may be accompanied by a variety of extra-articular manifestations. If the disease progresses to an advanced stage, patients may develop spinal ankylosis and structural deformity, which seriously affects the quality of life. At present, the pathogenesis of the disease has not been fully elucidated by modern medicine, while Chinese medicine has categorized it into the category of “paralysis” and named it as “big hunchback”, believing that its pathogenesis is characterized by “root deficiency with branch excess”. Based on this theory, this article focuses on the characteristics of deficiency and solidity. Based on this theory, this article systematically discusses the strategy of diagnosis and treatment of ankylosing spondylitis by focusing on the two major pathologies of deficiency and actuality, with a view to providing new diagnostic and therapeutic ideas for clinical practice.
文章引用:张睿, 何宴徽, 高丽娟. 从“虚实”两端论治强直性脊柱炎[J]. 临床个性化医学, 2025, 4(6): 72-76. https://doi.org/10.12677/jcpm.2025.46479

参考文献

[1] 中华医学会风湿病学分会. 强直性脊柱炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010, 14(8): 557-559.
[2] Wroński, J. and Fiedor, P. (2018) The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer than We Thought? The Journal of Clinical Pharmacology, 59, 445-462. [Google Scholar] [CrossRef] [PubMed]
[3] 王文奕, 纪清. 强直性脊柱炎康复综合治疗研究进展[J]. 辽宁中医药大学学报, 2013, 15(10): 204-209.
[4] 杨晓松. 强直性脊柱炎诊疗进展[J]. 中国全科医学, 2017, 20(S3): 218-221.
[5] 王承德, 沈丕安, 胡荫奇. 实用中医风湿病学[M]. 第2版. 北京: 人民卫生出版社, 2009.
[6] 王振东, 杨娟娟, 李浩林, 等. 强直性脊柱炎的发病机制及中药干预研究进展[J]. 中国实验方剂学杂志, 2024, 30(22): 289-298.
[7] 李彦, 孟祥震. 强直性脊柱炎的中医溯源考析[J]. 浙江中医杂志, 2021, 56(4): 297-299.
[8] 李明波, 黄燕波, 刘俊城, 等. 黄芪桂枝五物汤治疗强直性脊柱炎的网络药理学探讨[J]. 山东大学学报(医学版), 2022, 60(3): 29-38.
[9] 顾铭钰, 李泽, 石明鹏, 等. 国医大师刘柏龄治疗强直性脊柱炎经验[J]. 中华中医药杂志, 2023, 38(4): 1568-1571.
[10] 潘峰, 伍嘉琪, 何羿婷. 补肾强督治偻汤治疗强直性脊柱炎患者的随机对照研究[J]. 中国中西医结合杂志, 2022, 42(5): 560-567.
[11] 吴晓惠, 李敏, 王贵梅, 等. 调肝治疗对改善强直性脊柱炎脊柱核心肌群运动能力的影响[J]. 中华中医药杂志, 2021, 36(6): 3754-3757.
[12] 罗静, 张丽宁, 周丽, 等. 补肾强督方治疗强直性脊柱炎研究进展[J]. 中华中医药杂志, 2020, 35(10): 5087-5091.
[13] 周星宇, 王新义, 张玉飞, 等. 补肾通督外治法治疗肾阳亏虚型强直性脊柱炎的疗效观察[J]. 针刺研究, 2025, 50(2): 183-189.
[14] 薛纯纯, 李晓锋, 笪巍伟, 等. 施杞辨治强直性脊柱炎经验[J]. 中华中医药杂志, 2022, 37(10): 5774-5778.
[15] 俞根初. 重订通俗伤寒论[M]. 北京: 中国中医药出版社, 2011: 143.
[16] 赵福雨, 刘英, 姜萍. 张鸣鹤教授“清热活血”法论治强直性脊柱炎经验[J]. 时珍国医国药, 2024, 35(1): 257-258.
[17] 周东海, 冯炯, 王俏, 等. 强直性脊柱炎湿邪致病病机与治法初探[J]. 中华中医药杂志, 2020, 35(4): 1814-1816.
[18] 罗兴业, 于静, 金明秀. 湿热痹阻型强直性脊柱炎病因病机与治疗浅析[J]. 实用中医内科杂志, 2025, 39(2): 93-96.
[19] 刘凯, 刘宇飞, 温博, 等. 通督泄热刺络拔罐法对湿热型强直性脊柱炎患者疼痛程度、血清炎症因子的影响[J]. 河北中医, 2024, 46(2): 259-262, 266.
[20] 刘宏渌, 冯兴华, 李丽, 等. 淫羊藿苷对强直性脊柱炎成纤维细胞向成骨型分化的影响及分子机制[J]. 中国中西医风湿病学杂志, 2005, 8(3): 35.